Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Cancer immunotherapy has achieved promising clinical progress over the recent years for its potential to treat metastatic tumors and inhibit their recurrences effectively. However, low patient response rates and dose‐limiting toxicity remain as major dilemmas for immunotherapy. Stimuli‐responsive nanoparticles (srNPs) combined with immunotherapy offer the possibility to amplify anti‐tumor immune responses, where the weak acidity, high concentration of glutathione, overexpressions of enzymes, and reactive oxygen species, and external stimuli in tumors act as triggers for controlled drug release. This review highlights the design of srNPs based on tumor microenvironment and/or external stimuli to combine with different anti‐tumor drugs, especially the immunoregulatory agents, which eventually realize synergistic immunotherapy of malignant primary or metastatic tumors and acquire a long‐term immune memory to prevent tumor recurrence. The authors hope that this review can provide theoretical guidance for the construction and clinical transformation of smart srNPs for controlled drug delivery in synergistic cancer immunotherapy.
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Cancer immunotherapy has achieved promising clinical progress over the recent years for its potential to treat metastatic tumors and inhibit their recurrences effectively. However, low patient response rates and dose‐limiting toxicity remain as major dilemmas for immunotherapy. Stimuli‐responsive nanoparticles (srNPs) combined with immunotherapy offer the possibility to amplify anti‐tumor immune responses, where the weak acidity, high concentration of glutathione, overexpressions of enzymes, and reactive oxygen species, and external stimuli in tumors act as triggers for controlled drug release. This review highlights the design of srNPs based on tumor microenvironment and/or external stimuli to combine with different anti‐tumor drugs, especially the immunoregulatory agents, which eventually realize synergistic immunotherapy of malignant primary or metastatic tumors and acquire a long‐term immune memory to prevent tumor recurrence. The authors hope that this review can provide theoretical guidance for the construction and clinical transformation of smart srNPs for controlled drug delivery in synergistic cancer immunotherapy.
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Zhang, Jin (Autor:in) / Lin, Yandai (Autor:in) / Lin, Zhe (Autor:in) / Wei, Qi (Autor:in) / Qian, Jiaqi (Autor:in) / Ruan, Renjie (Autor:in) / Jiang, Xiancai (Autor:in) / Hou, Linxi (Autor:in) / Song, Jibin (Autor:in) / Ding, Jianxun (Autor:in)
Advanced Science ; 9
01.02.2022
27 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Stimuli-responsive polymers for anti-cancer drug delivery
| British Library Online Contents | 2014
Stimuli-Responsive Triblock Polymers for Multipulse Drug Delivery
| British Library Online Contents | 2009
Stimuli-Responsive Triblock Polymers for Multipulse Drug Delivery
| British Library Online Contents | 2009
Metal–Organic Framework‐Based Stimuli‐Responsive Systems for Drug Delivery
| Wiley | 2019
Novel pH-responsive multilayer magnetic nanoparticles for controlled drug delivery
| British Library Online Contents | 2016